Abstract | OBJECTIVE: DESIGN: Open, uncontrolled pilot study. PATIENT(S): INTERVENTION(S):
CoQ(10) was administered orally; semen samples were collected at baseline and after 6 months of therapy. MAIN OUTCOME MEASURE (S): Semen kinetic parameters, including computer-assisted sperm data and CoQ(10) and phosphatidylcholine levels. RESULT(S):
CoQ(10) levels increased significantly in seminal plasma and in sperm cells after treatment. Phosphatidylcholine levels also increased. A significant increase was also found in sperm cell motility as confirmed by computer-assisted analysis. A positive dependence (using the Cramer's index of association) was evident among the relative variations, baseline and after treatment, of seminal plasma or intracellular CoQ(10) content and computer-determined kinetic parameters. CONCLUSION(S): The exogenous administration of CoQ(10) may play a positive role in the treatment of asthenozoospermia. This is probably the result of its role in mitochondrial bioenergetics and its antioxidant properties.
|
Authors | Giancarlo Balercia, Fabrizio Mosca, Franco Mantero, Marco Boscaro, Antonio Mancini, Giuseppe Ricciardo-Lamonica, GianPaolo Littarru |
Journal | Fertility and sterility
(Fertil Steril)
Vol. 81
Issue 1
Pg. 93-8
(Jan 2004)
ISSN: 0015-0282 [Print] United States |
PMID | 14711549
(Publication Type: Journal Article)
|
Chemical References |
- Coenzymes
- Phosphatidylcholines
- Ubiquinone
- coenzyme Q10
|
Topics |
- Adult
- Coenzymes
- Dietary Supplements
- Female
- Humans
- Infertility, Male
(drug therapy)
- Male
- Oligospermia
(drug therapy)
- Phosphatidylcholines
(metabolism)
- Pregnancy
- Pregnancy Rate
- Semen
(drug effects, metabolism)
- Sperm Count
- Treatment Outcome
- Ubiquinone
(analogs & derivatives, therapeutic use)
|